TTOO (OTC)
T2 BIOSYSTEMS INC
$0.002200
+0.000700 (+46.67%)
Prev close: $0.001500
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John J. Sperzel
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.78M
- Employees
- 182
- P/E (TTM)
- —
- P/B (TTM)
- -0.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2024 (Q2)
|
$-0.66 | $-0.99 | +0.3294 | +33.29% |
|
Mar 2024 (Q1)
|
$-2.66 | $-1.90 | -0.7628 | -40.21% |
|
Sep 2023 (Q3)
|
$-3.45 | $-3.93 | +0.4770 | +12.15% |
|
Jun 2023 (Q2)
|
$-8.00 | $-27.20 | +19.2003 | +70.59% |
Financial Statements
| Revenues | $7.68M |
| Benefits Costs and Expenses | $50.63M |
| Costs And Expenses | $49.33M |
| Nonoperating Income/Loss | -$1.30M |
| Operating Expenses | $49.33M |
| Selling, General, and Administrative Expenses | $22.84M |
| Depreciation and Amortization | $300.00K |
| Research and Development | $12.92M |
| Other Operating Expenses | $13.27M |
| Operating Income/Loss | -$41.66M |
| Income/Loss From Continuing Operations After Tax | -$42.95M |
| Income/Loss From Continuing Operations Before Tax | -$42.95M |
| Net Income/Loss | -$42.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$42.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.03 |
| Diluted Earnings Per Share | -$0.03 |
| Basic Average Shares | 13,167,609 |
| Diluted Average Shares | 13,167,609 |
| Assets | $18.08M |
| Current Assets | $9.79M |
| Inventory | $3.83M |
| Other Current Assets | $5.96M |
| Noncurrent Assets | $8.30M |
| Fixed Assets | $1.48M |
| Other Non-current Assets | $6.82M |
| Liabilities | $29.79M |
| Current Liabilities | $24.44M |
| Accounts Payable | $4.21M |
| Wages | $3.41M |
| Other Current Liabilities | $16.81M |
| Noncurrent Liabilities | $5.36M |
| Equity | -$11.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$11.71M |
| Liabilities And Equity | $18.08M |
| Net Cash Flow From Operating Activities | -$36.59M |
| Net Cash Flow From Operating Activities, Continuing | -$36.59M |
| Net Cash Flow From Investing Activities | $13.58M |
| Net Cash Flow From Investing Activities, Continuing | $13.58M |
| Net Cash Flow From Financing Activities | $14.38M |
| Net Cash Flow From Financing Activities, Continuing | $14.38M |
| Net Cash Flow | -$8.63M |
| Net Cash Flow, Continuing | -$8.63M |
| Comprehensive Income/Loss | -$42.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.95M |
| Other Comprehensive Income/Loss | $0.00 |